Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Neomed Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 51
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 25
Rounds per year 1.89
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.51
Exits 16
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Manufacturing
Summary

Neomed Management appeared to be the VC, which was created in 1997. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Neomed Management, startups are often financed by Andera Partners, Gimv, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Gimv, Legend Capital, BioMedPartners. In the next rounds fund is usually obtained by Andera Partners, OrbiMed, Gimv.

The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Creabilis, Wilson Therapeutics.

The overall number of key employees were 3.

The typical startup value when the investment from Neomed Management is 10-50 millions dollars. The top activity for fund was in 2014. The top amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. This Neomed Management works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Neomed Management:
Typical Co-investors
Neomed Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Neomed Management:

Funds with similar focus

Funds from Norway
Funds with similar focus located in Norway:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oxular

Health Care
Medical
Therapeutics
$37M01 Mar 2021 Oxford, Oxfordshire, United Kingdom

Axonics Modulation Technologies

Health Diagnostics
Medical
Medical Device
$14M02 May 2017 Irvine, California, United States

4Tech

Manufacturing
Medical Device
$29M09 Mar 2016 Galway

Axonics Modulation Technologies

Health Diagnostics
Medical
Medical Device
$38M22 Dec 2015 Irvine, California, United States

Sequana Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$9M23 Oct 2015 Zurich, Zurich, Switzerland

JenaValve Technology

Health Care
Medical
Medical Device
$26M07 Aug 2015 Bavaria

Avitide

Biotechnology
Health Care
Life Science
$7M06 Aug 2015 Lebanon, New Hampshire, United States

Sequana Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$25M25 Apr 2014 Zurich, Zurich, Switzerland

Wilson Therapeutics

Biotechnology
Health Care
Therapeutics
$40M16 Apr 2014 Stockholm County

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neomed Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 51
Average round size 27M
Rounds per year 1.89
Peak activity year 2014
Lead investments 6
Follow on index 0.51
Exits 16
Group Appearance index 0.98

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Oxular

Health Care
Medical
Therapeutics
$37M01 Mar 2021 Oxford, Oxfordshire, United Kingdom

Axonics Modulation Technologies

Health Diagnostics
Medical
Medical Device
$14M02 May 2017 Irvine, California, United States

4Tech

Manufacturing
Medical Device
$29M09 Mar 2016 Galway

Axonics Modulation Technologies

Health Diagnostics
Medical
Medical Device
$38M22 Dec 2015 Irvine, California, United States

Sequana Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$9M23 Oct 2015 Zurich, Zurich, Switzerland

JenaValve Technology

Health Care
Medical
Medical Device
$26M07 Aug 2015 Bavaria

Avitide

Biotechnology
Health Care
Life Science
$7M06 Aug 2015 Lebanon, New Hampshire, United States

Sequana Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$25M25 Apr 2014 Zurich, Zurich, Switzerland

Wilson Therapeutics

Biotechnology
Health Care
Therapeutics
$40M16 Apr 2014 Stockholm County
Crunchbase icon

Content report

The following text will be sent to our editors: